+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Forecast 2024-2030- Product Image
Global EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Forecast 2024-2030- Product Image
Sale

Global EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924680
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The EV-Based Liquid Biopsy Market size was estimated at USD 409.66 million in 2023, USD 473.12 million in 2024, and is expected to grow at a CAGR of 15.89% to reach USD 1,150.80 million by 2030.

EV-based liquid biopsy, encompassing the extraction and analysis of extracellular vesicles (EVs) from bodily fluids, represents a pioneering frontier in non-invasive cancer diagnostics and monitoring. EVs, which are lipid-bound particles released from cells, carry a wealth of molecular information, such as DNA, RNA, and proteins, reflective of the health status of their cells of origin. The major factors propelling the use of EV-based liquid biopsies include their non-invasive nature, the potential for early cancer detection, the capability to monitor disease progression and treatment response, and the ability to provide insights into tumor heterogeneity.

Nevertheless, this nascent technology faces challenges such as the need for standardized methods for EV isolation and analysis, sensitivity in detecting low-abundance EVs, and the interpretive complexity of the data obtained. Addressing these restraints requires rigorous research to establish uniform protocols, advances in analytical technologies to enhance sensitivity and specificity, and sophisticated bioinformatics tools for data interpretation. The development of point-of-care devices for real-time monitoring, integration with artificial intelligence for predictive analytics, and expansion into other diseases beyond cancer illustrate EV-based liquid biopsy’s profound impact on personalized medicine and diagnostic landscapes.

Regional Insights

In the Americas, particularly the United States, there's a high adoption rate of advanced diagnostic solutions, including EV-based liquid biopsies, driven by substantial investments in healthcare R&D and a robust regulatory framework spearheaded by the FDA. This environment fosters a competitive market landscape, with numerous biotech firms and startups pioneering in EV research and diagnostics. The APAC region, led by countries such as China and Japan, is witnessing major growth in the EV-based liquid biopsy sector, attributed to increasing healthcare expenditure, rising patient awareness, and escalating prevalence of cancer.

The region's focus is on the use, production, and development of innovative EV-based diagnostics supported by favorable government policies. However, the market here is somewhat fragmented owing to the vast geographical and economic diversities between countries. The EMEA region demonstrates a balanced mix of mature and emerging markets, with Western Europe at the forefront of adopting EV-based liquid biopsy techniques, backed by strong healthcare systems and high awareness about non-invasive diagnostic methods. The Middle Eastern and African markets are gradually picking up pace, with investments flowing in from public and private sectors to enhance healthcare infrastructure and services.

Market Trends by Segment

  • Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
  • End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio

Quest Diagnostics announces the successful completion of its acquisition of Haystack Oncology. This strategic move enriches Quest's portfolio with Haystack Oncology's minimal-residual disease (MRD) testing technology. Leveraging circulating tumor DNA (ctDNA), this advanced MRD testing technology significantly enhances the early detection capabilities for residual or recurring cancers, offering a transformative approach to guiding therapy choices. Quest Diagnostics plans to integrate this cutting-edge technology into developing novel blood-based laboratory services tailored for solid tumor cancers, marking a significant advancement in cancer diagnosis and treatment.

Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes

Agena Bioscience has solidified its partnership with nRichDX, transitioning from a technical collaboration to a commercial alliance to promote its products within the research community. This partnership heralds significant advancements by coupling Agena's MassARRAY technology with nRichDX's Revolution Sample Prep System, a combination poised to redefine the landscape of liquid biopsy applications. The Revolution Sample Prep System stands out by consistently achieving higher yield extraction of these elusive variant transcripts from bodily fluids, elevating the MassARRAY platform's sensitivity threshold for detecting rare genetic markers in cancer.

Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection

Mercy BioAnalytics, Inc., an innovator in cancer detection through extracellular vesicle-based liquid biopsies, announced the successful closure of a notable USD 41 million in Series A funding. This achievement was led by Novalis LifeSciences and received robust support from a prestigious assembly of investors, including Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Cancer Society BrightEdge, and Broadway Angels. The investment aims to further the development of Mercy BioAnalytics' Mercy Halo platform, which stands out for its exceptional clinical sensitivity and specificity.

Key Company Profiles

The report delves into recent significant developments in the EV-Based Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agena Bioscience, Agilent Technologies, Inc., ALS Automated Lab Solutions GmbH, ANGLE PLC, Bio-Rad Laboratories, Inc, Bio-Techne Corporation, BioFluidica, Biological Dynamics, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Co. KG, Clinomics Europe Ltd., Corning Incorporated, ExosomeDx, Horiba Ltd., Illumina, Inc., Lonza Group Ltd., Malvern Panalytical Ltd., Mercy BioAnalytics, Inc., MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH, Mursla Bio, Nanostics Inc., PerkinElmer, Inc., Qiagen N.V., Quest Diagnostics, System Biosciences, LLC, and Thermo Fisher Scientific, Inc.

This research report offers invaluable insights into various crucial aspects of the EV-Based Liquid Biopsy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer and need for early intervention
5.1.1.2. Increasing preference for non-invasive diagnostic procedures
5.1.2. Restraints
5.1.2.1. High cost of EV-based liquid biopsy technologies
5.1.3. Opportunities
5.1.3.1. Advancements in EV-based liquid biopsy procedures
5.1.3.2. Favorable government approvals for liquid biopsy
5.1.4. Challenges
5.1.4.1. Technical complications of performing EV-based liquid biopsy
5.2. Market Segmentation Analysis
5.2.1. Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
5.2.2. End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. EV-Based Liquid Biopsy Market, by Type
6.1. Introduction
6.2. Assay Kits
6.3. Instruments
6.4. Services
7. EV-Based Liquid Biopsy Market, by Application
7.1. Introduction
7.2. Early Cancer Screening
7.3. Recurrence Monitoring
7.4. Therapy Selection
7.5. Treatment Monitoring
8. EV-Based Liquid Biopsy Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Clinical Laboratories
8.4. Pharmaceutical & Biotechnology Companies
9. Americas EV-Based Liquid Biopsy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific EV-Based Liquid Biopsy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa EV-Based Liquid Biopsy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio
12.3.2. Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes
12.3.3. Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
FIGURE 2. EV-BASED LIQUID BIOPSY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EV-BASED LIQUID BIOPSY MARKET DYNAMICS
FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 53. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 58. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 59. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 64. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 87. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 92. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 93. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 105. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 110. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 141. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 146. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 161. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 166. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 167. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 178. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 179. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 184. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 185. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 190. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 197. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 202. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 215. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 220. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 221. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 226. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 227. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 232. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 251. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 256. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 274. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 287. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 288. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abcam PLC
  • Agena Bioscience
  • Agilent Technologies, Inc.
  • ALS Automated Lab Solutions GmbH
  • ANGLE PLC
  • Bio-Rad Laboratories, Inc
  • Bio-Techne Corporation
  • BioFluidica
  • Biological Dynamics
  • Bristol-Myers Squibb
  • C.H. Boehringer Sohn AG & Co. KG
  • Clinomics Europe Ltd.
  • Corning Incorporated
  • ExosomeDx
  • Horiba Ltd.
  • Illumina, Inc.
  • Lonza Group Ltd.
  • Malvern Panalytical Ltd.
  • Mercy BioAnalytics, Inc.
  • MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH
  • Mursla Bio
  • Nanostics Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • System Biosciences, LLC
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 473.12 Million
Forecasted Market Value ( USD ) by 2030 $ 1150.8 Million
Compound Annual Growth Rate15.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Global EV-Based Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Workflow, Sample Type, End User, Technology, Regional Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2032 - Product Image

Global EV-Based Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Workflow, Sample Type, End User, Technology, Regional Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2032

  • Report
  • 166 Pages
  • Global
From
Liquid Biopsy Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Liquid Biopsy Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Breast Cancer Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 142 Pages
  • Global
From
The Worldwide Market for Liquid Biopsy, 6th Edition - Product Image

The Worldwide Market for Liquid Biopsy, 6th Edition

  • Report
  • 220 Pages
  • Global
From
Global Non-Invasive Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Technology (Next Generation Sequencing (NGS), RT-PCR and dPCR), End-user - Forecast 2024-2030 - Product Image

Global Non-Invasive Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Technology (Next Generation Sequencing (NGS), RT-PCR and dPCR), End-user - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.